Global 3D Cell Culture Market Research Report 2021

A 3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g. a petri dish), a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. These three-dimensional cultures are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. Approximately 300 spheroids are usually cultured per bioreactor.
The global 3D cell culture market is relatively concentrated; the sales of top nine manufacturers account about 68.23% of total global Production in 2016. The largest manufacture of 3D cell culture is Thermo Fisher Scientific; its Production is 252.73 K Unit in 2016. The next is Corning and Lonza Group.
North America is the largest consumption region of 3D cell culture in 2016. In 2016, the sales of 3D cell culture is about 470 K Unit in North America; its sales proportion of total global sales exceeds 36%.The next is Europe. Asia has a large growth rate of 3D cell culture.
Cancer research is currently the most well established application area and accounts for 40.05% of the present 3D culture market. Drug Discovery has also emerged quite popular with 36.25% of the current market share. Stem cells and regenerative medicine together capture a share of 24.08% in the current 3D culture market and would gradually gain focus as the market matures in the field of therapeutics in 2016.

The global 3D Cell Culture market was valued at US$ 663.3 million in 2019 and is expected to reach US$ 1584.7 million by the end of 2026, growing at a CAGR of 13.1% during 2021-2026.
This report focuses on 3D Cell Culture volume and value at the global level, regional level and company level. From a global perspective, this report represents overall 3D Cell Culture market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global 3D Cell Culture Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Scaffold-based
Scaffold-free

Segment by Application
Cancer Research
Stem Cell Research
Drug Discovery
Regererative Medicine

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Thermo Fisher Scientific
Corning
Lonza Group
Kuraray Co
Merck Kgaa
Insphero
N3d Bioscience
Reprocell Incorporated
3D Biotek